Alzheimer's

SHUTTERSTOCK

New Research From Oregon State University Could Help People With Alzheimer’s And Parkinson’s

The research is 10 years in the making and scientists discovered a new class of potential drug targets.

Mar 1, 2022

An epic tug of war is playing out behind the scenes over whether the government should pay for Aduhelm, a controversial Alzheimer’s drug that scientists say has not been proven to work./Lydia Zuraw/KHN

Inside The Tactical Tug Of War Over The Controversial Alzheimer’s Drug

Pharmaceutical industry and patients representatives want to stop restricting Medicare funding for a controversial Alzheimer’s drug. Critics say it should never have been approved.

Feb 17, 2022

Shutterstock

New Alzheimer’s Drug Manufacturer Launches Controversial Campaign

Facing a host of challenges, Aduhelm’s makers are running an educational campaign directed at consumers who are worried about whether their forgetfulness is a sign of disease.

Jul 24, 2021

SHUTTERSTOCK

Why We May Never Know Whether The $56,000-A-Year Alzheimer’s Drug Actually Works

Scientists may have to wait many years to find out whether Aduhelm is actually effective because the drug was approved using FDA's accelerated pathway.

Jul 13, 2021

Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?

Prescriptions for a controversial new drug for Alzheimer's could run $56 billion a year, putting a significant financial burden on Medicare, the health insurance for the elderly.

Jul 6, 2021